Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Adjunctive Use of Olanzapine in Mood Disorders: Five Case Reports

Adjunctive Use of Olanzapine in Mood Disorders: Five Case Reports Olanzapine has emerged as an atypical antipsychotic with few side effects and potentially superior efficacy in the treatment of schizophrenia. To our knowledge there have been few published reports of olanzapine in the treatment of mood disorders. We report on the adjunctive use of this medication in three subjects with mania and two with depression. Response occurred rapidly and patients tolerated the medication. Olanzapine offers promise in the treatment of mood disorders. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Springer Journals

Adjunctive Use of Olanzapine in Mood Disorders: Five Case Reports

Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/adjunctive-use-of-olanzapine-in-mood-disorders-five-case-reports-Y43ht6iyjr
Publisher
Springer Journals
Copyright
Copyright © 1997 by American Academy of Clinical Psychiatrists
Subject
Medicine & Public Health; Neurology; Psychiatry; Psychopharmacology
ISSN
1040-1237
eISSN
1573-3238
DOI
10.1023/A:1022312612221
Publisher site
See Article on Publisher Site

Abstract

Olanzapine has emerged as an atypical antipsychotic with few side effects and potentially superior efficacy in the treatment of schizophrenia. To our knowledge there have been few published reports of olanzapine in the treatment of mood disorders. We report on the adjunctive use of this medication in three subjects with mania and two with depression. Response occurred rapidly and patients tolerated the medication. Olanzapine offers promise in the treatment of mood disorders.

Journal

Annals of Clinical Psychiatry – Springer Journals

Published: Sep 18, 2004

References

  • Atypical antipsychotic drugs and long-term outcome in schizophrenia
    Weiden, P; Aquila, R; Standard, J
  • Psychoactive drugs in mania: A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol
    Shopsin, B; Gershon, S; Thompson, H
  • Comparison of lithium carbonate and chlorpromazine in the treatment of mania: Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group
    Prien, RF; Caffey, EM; Klett, CJ
  • Comparison of efficacy of lithium carbonate and chlorpromazine in mania: Report of collaborative study group on treatment of mania in Japan
    Takahashi, R; Sakuma, A; Itoh, K
  • Handbook of Lithium Therapy
    Kukopulos, A; Tondo, L
  • The incidence of depressive symptoms during recovery from hypomania
    Morgan, HG
  • Mania, psychosis, and antipsychotics
    McElroy, SA; Keck, PE; Strakowski, SM